tiprankstipranks
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719)
HKEX:0719
0719
Shandong Xinhua Pharmaceutical Company Limited Class H
RESEARCH TOOLSreports
Holding HK:0719?
Track your performance easily

Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Stock Price & Analysis

0 Followers

0719 Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

0.70%98.86%
Insiders
― Other Institutional Investors
98.86% Public Companies and
Individual Investors

0719 FAQ

What was Shandong Xinhua Pharmaceutical Company Limited Class H’s price range in the past 12 months?
Shandong Xinhua Pharmaceutical Company Limited Class H lowest stock price was HK$4.80 and its highest was HK$8.05 in the past 12 months.
    What is Shandong Xinhua Pharmaceutical Company Limited Class H’s market cap?
    Currently, no data Available
    When is Shandong Xinhua Pharmaceutical Company Limited Class H’s upcoming earnings report date?
    Shandong Xinhua Pharmaceutical Company Limited Class H’s upcoming earnings report date is Mar 26, 2025 which is in 124 days.
      How were Shandong Xinhua Pharmaceutical Company Limited Class H’s earnings last quarter?
      Shandong Xinhua Pharmaceutical Company Limited Class H released its earnings results on Oct 29, 2024. The company reported HK$0.126 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.126.
        Is Shandong Xinhua Pharmaceutical Company Limited Class H overvalued?
        According to Wall Street analysts Shandong Xinhua Pharmaceutical Company Limited Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Shandong Xinhua Pharmaceutical Company Limited Class H pay dividends?
          Shandong Xinhua Pharmaceutical Company Limited Class H pays a Annually dividend of HK$0.03 which represents an annual dividend yield of 5.03%. See more information on Shandong Xinhua Pharmaceutical Company Limited Class H dividends here
            What is Shandong Xinhua Pharmaceutical Company Limited Class H’s EPS estimate?
            Shandong Xinhua Pharmaceutical Company Limited Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Shandong Xinhua Pharmaceutical Company Limited Class H have?
            Shandong Xinhua Pharmaceutical Company Limited Class H has 195,000,000 shares outstanding.
              What happened to Shandong Xinhua Pharmaceutical Company Limited Class H’s price movement after its last earnings report?
              Shandong Xinhua Pharmaceutical Company Limited Class H reported an EPS of HK$0.126 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.449%.
                Which hedge fund is a major shareholder of Shandong Xinhua Pharmaceutical Company Limited Class H?
                Currently, no hedge funds are holding shares in HK:0719
                ---

                Shandong Xinhua Pharmaceutical Company Limited Class H Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                8.27%
                12-Months-Change

                Fundamentals

                Return on Equity
                9.54%
                Trailing 12-Months
                Asset Growth
                15.01%
                Trailing 12-Months

                Company Description

                Shandong Xinhua Pharmaceutical Company Limited Class H

                Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Eminence Enterprise Limited
                China Dredging Environment Protection Holdings Limited
                Shenguan Holdings (Group) Limited
                Khoon Group Limited
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis